A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC), according to research published in the February 20th 2018, print issue of the Journal of Clinical Oncology by a multi-institutional team of researchers with The Ohio State… Continue reading “Liquid Biopsy” Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer